{"id":"https://openalex.org/W2149175164","doi":"https://doi.org/10.1016/j.jval.2013.03.1485","title":"Economic evaluation of apixaban for atrial fibrillation in costa Rica","display_name":"Economic evaluation of apixaban for atrial fibrillation in costa Rica","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W2149175164","doi":"https://doi.org/10.1016/j.jval.2013.03.1485","mag":"2149175164"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2013.03.1485","doi":"https://doi.org/10.1016/j.jval.2013.03.1485","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.03.1485","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2013.03.1485","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111650599","display_name":"A.A. Rosado-Buzzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Rosado-Buzzo","raw_affiliation_strings":["Links & Links S.A, de C.V., Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Links & Links S.A, de C.V., Mexico City, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091320016","display_name":"Lourdes Garc\u00eda-Mollinedo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Garcia-Mollinedo","raw_affiliation_strings":["Links & Links S.A, de C.V., Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Links & Links S.A, de C.V., Mexico City, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066178045","display_name":"G. Luna-Casas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Luna-Casas","raw_affiliation_strings":["Links & Links S.A, de C.V., Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Links & Links S.A, de C.V., Mexico City, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"M.A. Lutz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.A. Lutz","raw_affiliation_strings":["Pfizer Central America and the Caribbean, San Jose, Costa Rica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Central America and the Caribbean, San Jose, Costa Rica","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047807912","display_name":"J.P. Bogantes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.P. Bogantes","raw_affiliation_strings":["Pfizer Central America and the Caribbean, San Jose, Costa Rica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Central America and the Caribbean, San Jose, Costa Rica","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J.M. Sobrino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.M. Sobrino","raw_affiliation_strings":["Links & Links S.A, de C.V., Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Links & Links S.A, de C.V., Mexico City, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"G. Cuesta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Cuesta","raw_affiliation_strings":["Pfizer Central America and the Caribbean, Escaz\u00fa, San Jose, Costa Rica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Central America and the Caribbean, Escaz\u00fa, San Jose, Costa Rica","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110172905","display_name":"J.F. Mould","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.F. Mould","raw_affiliation_strings":["Pfizer, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.4363,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.71037824,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"3","first_page":"A286","last_page":"A286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.8859999775886536},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9470000267028809},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8080000281333923},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.9350000023841858},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9990000128746033},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9470000267028809},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.9129999876022339},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6949999928474426},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9549999833106995},{"id":"https://openalex.org/keywords/decision-tree","display_name":"decision tree","score":0.5630000233650208},{"id":"https://openalex.org/keywords/costa-rica","display_name":"Costa Rica","score":0.5730000138282776},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.4860000014305115},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.4350000023841858},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.9558080434799194},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8709138631820679},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.8684009313583374},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.8136139512062073},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8050022721290588},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.7447819709777832},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5506073832511902},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.5071961879730225},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.43510088324546814},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4169192910194397},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3952983021736145},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.36148780584335327},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3365859091281891},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2013.03.1485","doi":"https://doi.org/10.1016/j.jval.2013.03.1485","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.03.1485","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2013.03.1485","doi":"https://doi.org/10.1016/j.jval.2013.03.1485","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.03.1485","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1985693816","https://openalex.org/W2110544353","https://openalex.org/W2117209291","https://openalex.org/W2067882985","https://openalex.org/W1836721965","https://openalex.org/W2121297517","https://openalex.org/W1995384927","https://openalex.org/W2119748408","https://openalex.org/W3111638546","https://openalex.org/W2093488633"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}